Tata Chemicals Q1 FY27: Consolidated PAT drops to Rs 60 cr; standalone PAT up 12% to Rs 343 cr
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than Nifty Smallcap 250 and 4.0 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue grew 14.4% YoY to Rs 4,255 cr. Total PAT fell to Rs 60 cr from Rs 316 cr as Industrial Essentials segment swung to a Rs 70 cr loss (vs Rs 131 cr profit). Equity shareholders saw a Rs 17 cr loss. Standalone revenue rose 9.6% to Rs 1,281 cr with PAT up 12% to Rs 343 cr. No exceptional items this quarter. Consolidated operating margin compressed to 5.15% from 9.92%; standalone expanded to 19.44%.
Mixed: standalone strong with margin expansion, but consolidated weak on US/Industrial segment losses. Equity holders posted a loss this quarter.